CERUMENEX Drug Patent Profile
✉ Email this page to a colleague
When do Cerumenex patents expire, and what generic alternatives are available?
Cerumenex is a drug marketed by Pharm Res Assoc and is included in one NDA.
The generic ingredient in CERUMENEX is trolamine polypeptide oleate condensate. Additional details are available on the trolamine polypeptide oleate condensate profile page.
Summary for CERUMENEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 130 |
Patent Applications: | 3,962 |
DailyMed Link: | CERUMENEX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CERUMENEX
US Patents and Regulatory Information for CERUMENEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharm Res Assoc | CERUMENEX | trolamine polypeptide oleate condensate | SOLUTION/DROPS;OTIC | 011340-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |